This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• B. Riley Securities analyst Eric Wold downgraded the rating for Cinemark Holdings, Inc. CNK from Buy to Neutral and maintained the price target of $31. Cinemark shares gained 1.3% to close at $28.17 on Monday. See how other analysts view this stock.
• Citigroup analyst Thomas Palmer downgraded The Hershey Company HSY from Neutral to Sell and slashed the price target from $195 to $182. Hershey shares rose 0.04% to close at $196.41 on Monday. See how other analysts view this stock.
• Alembic Global analyst Peter Skibitski downgraded the rating for Northrop Grumman Corporation NOC from Overweight to Neutral and announced a price target of $560. Northrop Grumman shares gained 0.5% to close at $512.00 on Monday. See how other analysts view this stock.
• Citigroup analyst Alicia Yap downgraded PDD Holdings Inc. PDD from Buy to Neutral and cut the price target from $194 to $120. PDD shares dipped 28.5% to settle at $100.00 on Monday. See how other analysts view this stock.
• Maxim Group analyst Jason McCarthy downgraded the rating for Cyclo Therapeutics, Inc. CYTH from Buy to Hold. Cyclo Therapeutics shares rose 6.1% to close at $0.8277 on Monday. See how other analysts view this stock.

Considering buying HSY stock? Here’s what analysts think: